Abaxis Inc (ABAX) Return on Investment ROI from the fourth quarter of 2018 to fourth quarter of 2017 and for the year 2018, average high and low, overall ranking from Mar 31 2018 to Mar 31 2017 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abaxis Inc  (ABAX)


Abaxis Inc's ROI from its fourth quarter of 2018 to the fourth quarter of 2017 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Abaxis Inc's ROI in the fourth quarter of 2018?
Abaxis Inc achieved a return on average invested assets (ROI) of 9.35 % in its fourth quarter of 2018, which is below Abaxis Inc's average return on investment, which stands at 11.66%.

ROI has improved compared to 8.86% in the third quarter of 2018, due to net income growth.

Within the Healthcare sector 91 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2018 from 679 to 955.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2018)
IV. Quarter		 (Dec 31 2017)
III. Quarter		 (Sep 30 2017)
II. Quarter		 (Jun 30 2017)
II. Quarter		 (Mar 31 2017)
IV. Quarter
Y / Y Investment Change TTM 9.21 % 9.97 % 9.86 % 9.59 % 8.84 %
Y / Y Net Income Change TTM -18.5 % -27.39 % 0.52 % 104.15 % 269.21 %
Investment (TTM) in Millions 297 287 283 273 272
Return On Investment (TTM) 9.35 % 8.86 % 10 % 12.03 % 12.53 %
ABAX's Overall Ranking # 955 # 679 # 658 # 794 #
Seq. Investment Change TTM 2.24 % 2.02 % 2.26 % 2.39 % 2.96 %
Seq. Net Income Change TTM 7.92 % -9.58 % -15.02 % -1.71 % -3.85 %
Net Income (TTM) in Millions 27 25 27 32 33

ABAX Company Profile >> Back to ABAX Roi Comparisons >> See Annual ABAX Return On Investment



Return On Investment ABAX's Ranking
Within: No.
Industry # 4
Sector # 92
Overall # 955

Return On Investment Statistics
High Average Low
15.55 %
11.66 %
7.38 %
(Mar 31 2013)   (Mar 31 2014)







Financial Statements
Abaxis Inc's IV. Quarter Investments $ 297 Millions ABAX's Balance sheet
Abaxis Inc's IV. Quarter Income $ 10 Millions Quarterly ABAX's Income Statement
ABAX's Income by Division See ABAX's Income by Division


ABAX Annual Return On Investment (Mar 31 2018)
2018		 (Mar 31 2017)
2017		 (Mar 31 2016)
2016		 (Mar 31 2015)
2015		 (Mar 31 2014)
2014
Total Investments in Millions 297 272 242 228 200
Y / Y Investment Growth 9.19 % 12.38 % 6.33 % 13.82 % 10.11 %
Net Income in Millions 27 33 32 27 14
Y / Y Net Income Growth -16.93 % 3.43 % 15.73 % 92.68 % -48.34 %
Annual Return On Investment 9.14 % 12.02 % 13.06 % 12 % 7.09 %


Annual Roi Comment
In the fiscal year 2018 ROI decreased relative to the previous year to 9.14 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ABAX's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ABAX's Competitors
Subscribers only: Roi for Abaxis Inc's Suppliers
Subscribers only: Return On Investment for ABAX's Customers

Other Ratios
ABAX's Roa ABAX's Inventory Turnover Ratio ABAX's Growth Rates ABAX's Dividend Statistics
ABAX's Profitability Ratios ABAX's Asset Turnover Ratio ABAX's Dividend Growth
ABAX's Roe ABAX's Valuation Ratios ABAX's Financial Strength Ratios ABAX's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2018, within Healthcare Sector ROI
Idexx Laboratories Inc  24.74 %
Nrc Health  24.67 %
Tivity Health Inc   24.62 %
Regenxbio Inc   23.71 %
Align Technology inc   22.50 %
Cba Florida Inc   22.26 %
Halozyme Therapeutics Inc   21.34 %
United Therapeutics Corporation  21.18 %
Mettler toledo International Inc   20.82 %
Pfizer Inc  20.35 %
Supernus Pharmaceuticals inc   19.24 %
Alpha Pro Tech Ltd   18.53 %
Atrion Corporation  18.30 %
Regeneron Pharmaceuticals Inc   18.23 %
Bio rad Laboratories Inc   17.98 %
Plx Pharma Inc   17.57 %
Abiomed Inc   17.46 %
Enanta Pharmaceuticals Inc  17.25 %
Pacific Health Care Organization Inc  17.22 %
Cambrex Corp  16.65 %
Chemed Corporation  16.64 %
Escalon Medical Corp   16.50 %
Biospecifics Technologies Corp  16.33 %
Lemaitre Vascular Inc   16.13 %
Encision Inc   15.56 %
Masimo Corp  15.37 %
Jrsis Health Care Corp  15.28 %
Biogen Inc   15.25 %
Intuitive Surgical Inc   14.98 %
Carlisle Companies Incorporated  14.44 %

Date modified: 2026-07-06T17:55:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.